Perlegen s Phyllis Whiteley on the New PGx Flavor of Drug-Licensing Deals | GenomeWeb

Name: Phyllis Whiteley

Position: Senior Vice President of Business Development & Licensing, Perlegen Sciences, 2004 — the present

Background: Several positions within F. Hoffman La Roche: Vice President Business Development and Global Licensing Director in Basel, Switzerland; Vice President Global Alliances Research, North America; Vice President of Strategic Portfolio Management, Global Pharma Research Strategy; 1994 — 2004

Education: PhD in Pharmacology, Washington University in St. Louis, Mo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.